Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/24/2012 | US20120128665 Preselection of subjects for therapeutic treatment based on hypoxic status |
05/24/2012 | US20120128660 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention |
05/24/2012 | US20120128659 Agents capable of downregulating an msf-a - dependent hif-1alpha and use thereof in cancer treatment |
05/24/2012 | US20120128658 Rage g82s-related methods and compositions for treating inflammatory disorders |
05/24/2012 | US20120128652 Endolysin plyp40 |
05/24/2012 | US20120128646 Methods and compositions for the treatment of autoimmune disease |
05/24/2012 | US20120128642 Potency markers |
05/24/2012 | US20120128632 Identity markers |
05/24/2012 | US20120128626 Anti-il-6 antibodies for the treatment of anemia |
05/24/2012 | US20120128592 Surface enhanced raman spectroscopy (sers) compounds and methods of their preparation |
05/24/2012 | US20120128585 Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level |
05/24/2012 | US20120128584 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
05/24/2012 | US20120128550 Method and a device for treating microparticles |
05/24/2012 | US20120128536 Molecularly printed polymer for detecting the pentraxin, and method for preparing same |
05/24/2012 | US20120128535 Bridged Element For Detection Of A Target Substance |
05/24/2012 | US20120127224 Image registration on edible substrates |
05/24/2012 | US20120126648 Machine and method for monitoring the state of a safety bearing of a machine |
05/24/2012 | US20120125789 Enzyme stabilization in electrochemical sensors |
05/24/2012 | US20120125788 Electrochemical affinity biosensor system and methods |
05/24/2012 | US20120125774 Analysis Chip and Analysis Apparatus |
05/24/2012 | US20120125773 Analysis Chip and Analysis Apparatus |
05/24/2012 | US20120125767 Analyte Sensors and Methods of Use |
05/24/2012 | US20120125086 Cartridge for body fluid measuring strips and a body fluid measurement device |
05/24/2012 | US20120125082 Method of Selecting a Fragrance |
05/24/2012 | US20120125079 Apparatus for on-line continuous chlorine analysis in turbid water and process streams |
05/24/2012 | US20120125076 Portable metered flow apparatus for calibration/bump testing |
05/24/2012 | DE202010017710U1 Vorrichtung zur Analyse flüssiger Proben An apparatus for analyzing liquid samples |
05/24/2012 | DE10253917B4 Gassensor Gas sensor |
05/24/2012 | DE102011119305A1 Material testing method for thermoplastic continuous fiber-reinforced semi-finished products, subjecting fiber assembly to material testing process, and executing test procedure under test conditions that meet semi-finished product test |
05/24/2012 | DE102011086568A1 Amplifying signals in heterogeneous binding assays based on donor or receptor complex, comprises adding particle of first particle class and particle of second particle class to donor or receptor complex and optionally repeating steps |
05/24/2012 | DE102011055265A1 Automatenfähiger Immunoassay für biogene Amine Machine-capable immunoassay for biogenic amines |
05/24/2012 | DE102010051810A1 Bilderzeugende Massenspektrometrie mit Protein-Identifizierung An imaging mass spectrometry protein identification |
05/24/2012 | DE102009043426B4 Vorrichtung und Verfahren zur Gewinnung, zum Nachweis und zur Analyse von Zellen in einem mikrofluidischen System Device and method for obtaining, for the detection and analysis of cells in a microfluidic system |
05/24/2012 | DE102009000931B4 Verfahren zur Qualitätsbestimmung von zur Dacheindeckung vorgesehenem Reet sowie zur Prüfung von Verfahren zum prophylaktischen Reetschutz Method for determining the quality of the roofing thatch and the intended to examine procedures for prophylactic Reetschutz |
05/24/2012 | DE102007048636B4 Marker zur Diagnose von Krebs Marker for diagnosing cancer |
05/24/2012 | CA2845790A1 Determination of the thrombogenic power of human immunoglobulins |
05/24/2012 | CA2818511A1 Device and method for measuring biomarkers |
05/24/2012 | CA2818491A1 Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein |
05/24/2012 | CA2818486A1 Ncrna and uses thereof |
05/24/2012 | CA2818234A1 Generation of neural stem cells from human trophoblast stem cells |
05/24/2012 | CA2817887A1 Viability cell counting by differential light absorption |
05/24/2012 | CA2817393A1 Use of quinolinone derivatives as a research tool |
05/24/2012 | CA2817316A1 Device and method for immunotrials |
05/24/2012 | CA2816645A1 A guided structured testing kit |
05/24/2012 | CA2813451A1 Methods of diagnosing and treating neurodegenerative diseases |
05/24/2012 | CA2787954A1 Biomarkers |
05/24/2012 | CA2722722A1 Polar component detection |
05/23/2012 | EP2455774A1 Sensor device and method for its operation |
05/23/2012 | EP2455760A1 Analysis reagent and analysis device having the analysis reagent carried therein |
05/23/2012 | EP2455759A1 Mass spectrometry imaging with substance identification |
05/23/2012 | EP2455758A1 Method for measurement of glycoprotein, method for detection of hepatic diseases, reagent for quantification of glycoprotein, and sugar chain marker glycoprotein as measure of disease conditions of hepatic diseases |
05/23/2012 | EP2455757A1 Method for strengthening signals in heterogeneous binding assays |
05/23/2012 | EP2455756A1 Cell-based screening assay for inhibitors of NET formation |
05/23/2012 | EP2455755A2 Proteaoglycan-4 as marker for chronic renal failure |
05/23/2012 | EP2455751A1 Method for quantifying protein |
05/23/2012 | EP2455750A1 Method for specific cleavage of n-c bond in peptide main chain |
05/23/2012 | EP2455742A1 Improved dissolution test equipment |
05/23/2012 | EP2455488A2 Methods and compositions for DNA manipulation |
05/23/2012 | EP2455487A2 Chromatographic system for nucleic acid detection |
05/23/2012 | EP2455469A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof |
05/23/2012 | EP2455458A2 Covalent tethering of functional groups to proteins |
05/23/2012 | EP2455457A2 Covalent tethering of functional groups to proteins |
05/23/2012 | EP2455456A1 Use of kinesin inhibitors in HIV infection treatment and a method for screening them |
05/23/2012 | EP2455397A1 Mutant ras polypeptide crystal |
05/23/2012 | EP2455395A1 MCM6 monoclonal antibodies and methods for their use in the detection of cervical disease |
05/23/2012 | EP2455389A1 Sugar chain marker as measure of disease conditions of hepatic diseases |
05/23/2012 | EP2455163A1 Holding device for testing strip |
05/23/2012 | EP2455100A2 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
05/23/2012 | EP2454599A1 INHIBITORS OF THE NITRATION OF AMYLOID ß PEPTIDES AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE |
05/23/2012 | EP2454598A1 Drug selection for gastric cancer therapy using antibody-based arrays |
05/23/2012 | EP2454597A1 Therapeutic peptides, polypeptides ans nucleic acid sequences |
05/23/2012 | EP2454596A1 Flap endonuclease-1 as a marker for cancer |
05/23/2012 | EP2454595A1 Temperature-compensated in-vivo sensor |
05/23/2012 | EP2454594A1 Use of animal cells for screening probiotic bacteria strains |
05/23/2012 | EP2454593A1 Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
05/23/2012 | EP2454592A1 Method and apparatus for determining an analyte parameter |
05/23/2012 | EP2454591A2 New tool for studying endothelial haematopoietic transition (eht) and epithelial-mesenchymal transition (emt) associated events |
05/23/2012 | EP2454590A2 A method of analyzing cellulose decay in cellulosic material hydrolysis |
05/23/2012 | EP2454589A1 Method of assaying 5-fu |
05/23/2012 | EP2454588A1 Nucleic acid analysis |
05/23/2012 | EP2454587A2 Devices, methods, and kits for determining analyte concentrations |
05/23/2012 | EP2454580A1 Method and apparatus for identifying the orientation of wood fibres |
05/23/2012 | EP2454508A2 Flame safety system for in situ process analyzer |
05/23/2012 | EP2454388A2 Methods and kits used in assessing cancer risk |
05/23/2012 | EP2454387A1 Urinary trypsin inhibitors as diagnostic aid for interstitial cystitis |
05/23/2012 | EP2454383A1 Znf217 a new prognostic and predictive biomarker of recurrent, invasive and metastatic phenotypes in breast cancer |
05/23/2012 | EP2454380A2 Diagnostic methods and compositions for treatment of cancer |
05/23/2012 | EP2454379A1 Nucleic acid expression construct and its use as a cell proliferation marker |
05/23/2012 | EP2454377A2 Mass spectrometric diagnosis of septicemia |
05/23/2012 | EP2454372A2 Treatment and diagnosis of immune disorders |
05/23/2012 | EP2454329A1 Novel fluorescent dyes and uses thereof |
05/23/2012 | EP2454271A2 Peptides whose uptake in cells is controllable |
05/23/2012 | EP2454269A1 Improved screening of biopolymers |
05/23/2012 | EP2454261A1 Imidazo[1,2-alpha]pyrazin-3(7h)-one derivatives bearing a new electron-rich structure |
05/23/2012 | EP2454260A1 Immunodetection and quantification of pyrazolopyrimidine sedatives |
05/23/2012 | EP2454018A1 Tube for separating portions of a sample |
05/23/2012 | EP2453926A2 Peptides whose uptake in cells is controllable |
05/23/2012 | EP2453883A1 Method for predicting the utility of administering nicotinic acid or a precursor or prodrug thereof to reduce the severity of side-effects of cancer treatment with nicotinamide phosphoribosyltransferase inhibitors |
05/23/2012 | EP2453871A1 Orally administered bacteria as vehicles for systemic delivery of agents |
05/23/2012 | EP2453838A2 Cosmetic use of lacritin-type polypeptides |